Sastasundar Ventures Ltd (HEALTHX) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Sastasundar Ventures Ltd reported sales of ₹446.85 Cr, operating profit of ₹-8.38 Cr (OPM -1.88%) and net profit of ₹1.99 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
HEALTHX quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 273.53 281.29 285.84 298.43 301.32 345.74 373.78 446.85 Expenses 278.25 304.99 311.04 292.37 323.93 356.1 398.97 455.23 Operating Profit -4.72 -23.7 -25.2 6.06 -22.61 -10.36 -25.19 -8.38 OPM -1.73% -8.43% -8.82% 2.03% -7.5% -3% -6.74% -1.88% Other Income -167.39 -14.06 21.91 25.38 5.34 13.62 12.8 12.83 Interest 0.06 0.05 0.01 0.09 0.04 0.17 0.49 0.59 Depreciation 1.45 1.43 1.34 1.17 1.33 2.17 1.94 1.89 Profit before tax -173.62 -39.24 -4.64 30.18 -18.64 0.92 -14.82 1.97 Tax -13.17% 1.99% -478.45% 11.9% -17.17% 59.78% -12.48% -0.51% Net Profit -154.78 -37.8 17.57 26.59 -15.44 0.37 -12.97 1.99 EPS in Rs -34.39 -8.47 4.3 7.52 -3.99 0.36 -3.51 0.8
HEALTHX profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 1,798 1,060 1,432 1,159 1,319 1,468 Expenses 684 1,168 1,456 1,177 1,371 1,534 Operating Profit 1,114 -107 -24 -19 -52 -67 OPM 62% -10% -1.7% -1.6% -4% -4.5% Other Income 3 -5 4 -179 57 45 Interest 3 2 1 0 1 1 Depreciation 4 8 9 6 7 7 Profit before tax 1,109 -122 -30 -204 -2 -31 Tax 22% -19% -119% -34% -39% - Net Profit 865 -99 6 -134 -1 -26 EPS in Rs 197.05 -22.7 2.79 -28.66 0.37 -6.34 Dividend Payout 0% 0% 0% 0% 0% -
HEALTHX balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 32 32 32 32 32 Reserves 722 731 638 650 609 Borrowings 9 4 1 5 26 Other Liabilities 441 383 300 321 269 Total Liabilities 1,204 1,149 970 1,008 936 Fixed Assets 107 110 102 117 117 CWIP 1 0 10 1 1 Investments 513 676 575 633 519 Other Assets 583 363 283 257 299 Total Assets 1,204 1,149 970 1,008 936
HEALTHX cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity -207 -112 36 -17 -74 Cash from Investing Activity 220 133 -34 -1 171 Cash from Financing Activity -11 -2 -2 0 -80 Net Cash Flow 1 19 0 -19 18 Free Cash Flow -212 -128 22 -27 -89 CFO/OP -8% 104% -172% 68% 133%
HEALTHX ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 4 12 9 3 2 Inventory Days 71 69 34 40 44 Days Payable 21 22 13 21 26 Cash Conversion Cycle 55 59 31 22 20 Working Capital Days 46 93 58 47 16 ROCE -7% -11% -3% -1% 0%